| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Department of Ophthalmology, Herlev Hospital, University of Copenhagen, Denmark.
PURPOSE. To investigate the passive bidirectional and active outward transport of fluorescein through the blood–retina barrier (BRB) in diabetic patients with clinically significant macular edema and in healthy controls.
METHODS. The passive and active transport of fluorescein through the BRB was quantitated by vitreous fluorometry. A previously developed method was used to model passive transport. A new simulation model was developed and evaluated for estimation of active transport. The study included 10 eyes of 5 healthy controls and 31 eyes of 20 diabetic patients with clinically significant diabetic macular edema (CSME) in at least one eye, totalling 25 eyes with CSME.
RESULTS. Passive permeability of fluorescein was increased by a factor of 12 in eyes with edema compared to healthy controls (edema, 23.7 nm/sec; healthy subjects, 1.9 nm/sec, P < 0.01), whereas the active transport was doubled (edema, 84.1 nm/sec; healthy subjects, 43.5 nm/sec, P < 0.01). Unlike active transport, passive permeability was related to the degree of retinopathy, in that eyes with severe non-proliferative diabetic retinopathy had a passive permeability that was significantly increased compared to moderate retinopathy (32.1 nm/sec and 14.6 nm/sec, respectively, P < 0.05). The passive movement quantitated with vitreous fluorometry was larger for diffuse and mixed leakage compared to focal (P = 0.07).
CONCLUSIONS. Insofar as the movement of fluorescein can be taken as a probe for the movement of electrolytes and water, the pathogenesis of diabetic macular edema seems to involve a disruption of the BRB, presumably its inner component. The active resorptive functions of the blood–retina barrier appear to be compensatorily increased to counteract edema formation, although the increase is too small to prevent edema in the face of severe leakage through the blood–retina barrier.
This article has been cited by other articles:
|
|
 |
|
  X. Zhang, S. Bao, D. Lai, R. W. Rapkins, and M. C. Gillies Intravitreal Triamcinolone Acetonide Inhibits Breakdown of the Blood-Retinal Barrier Through Differential Regulation of VEGF-A and Its Receptors in Early Diabetic Rat Retinas Diabetes, April 1, 2008; 57(4): 1026 - 1033. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Sander, D. N. Thornit, L. Colmorn, C. Strom, A. Girach, L. D. Hubbard, H. Lund-Andersen, and M. Larsen Progression of Diabetic Macular Edema: Correlation with Blood Retinal Barrier Permeability, Retinal Thickness, and Retinal Vessel Diameter Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 3983 - 3987. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Hernandez, A. Fonollosa, M. Garcia-Ramirez, M. Higuera, R. Catalan, A. Miralles, J. Garcia-Arumi, and R. Simo Erythropoietin Is Expressed in the Human Retina and It Is Highly Elevated in the Vitreous Fluid of Patients With Diabetic Macular Edema. Diabetes Care, September 1, 2006; 29(9): 2028 - 2033. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Strom, B. Sander, K. Klemp, L. P. Aiello, H. Lund-Andersen, and M. Larsen Effect of Ruboxistaurin on Blood-Retinal Barrier Permeability in Relation to Severity of Leakage in Diabetic Macular Edema Invest. Ophthalmol. Vis. Sci., October 1, 2005; 46(10): 3855 - 3858. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. A. Berkowitz, R. Roberts, H. Luan, J. Peysakhov, X. Mao, and K. A. Thomas Dynamic Contrast-Enhanced MRI Measurements of Passive Permeability through Blood Retinal Barrier in Diabetic Rats Invest. Ophthalmol. Vis. Sci., July 1, 2004; 45(7): 2391 - 2398. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B Sander, M Larsen, C Engler, B Moldow, and H Lund-Andersen Diabetic macular oedema: the effect of photocoagulation on fluorescein transport across the blood-retinal barrier Br. J. Ophthalmol., October 1, 2002; 86(10): 1139 - 1142. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Mori, T. Hikichi, J. Takahashi, T. Nagaoka, and A. Yoshida Dysfunction of Active Transport of Blood-Retinal Barrier in Patients With Clinically Significant Macular Edema in Type 2 Diabetes Diabetes Care, July 1, 2002; 25(7): 1248 - 1249. [Full Text] [PDF]
|
|
|
|
|
|
B Sander, M Larsen, C Engler, C Strom, B Moldow, N Larsen, and H Lund-Andersen Diabetic macular oedema: a comparison of vitreous fluorometry, angiography, and retinopathy Br. J. Ophthalmol., March 1, 2002; 86(3): 316 - 320. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
